TCTR20240423003
Recruiting
Not Applicable
Assessment of Safety and efficacy of continuous intravenous Labetalol infusion for blood pressure control in patients with spontaneous intracerebral hemorrhage
Faculty of Medicine, Thammasat University0 sites100 target enrollmentApril 23, 2024
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Blood pressure control and hematoma volume control in patients with spontaneous intracerebral hemorrhage
- Sponsor
- Faculty of Medicine, Thammasat University
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Spontaneous ICH
- •2\.Age more than 18 years
- •3\. No secondary causes: AVM, aneurysm
Exclusion Criteria
- •1\.Secondary causes of ICH: AVM, aneurysm
- •2\.Pregnancy
- •3\.Traumatic intracerebral hemorrhage
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the safety and efficacy of continuous use of skincare formulationsHealthyJPRN-UMIN000039938Beauty & Health Research Inc.45
Not yet recruiting
Not Applicable
To evaluate the efficacy and safety of regional block of the abdomen( between 2 muscles) using ultrasound guidance after laparoscopic nephrectomy surgery - a clinical trialHealth Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary systemCTRI/2020/03/023760All India Institute of Medical Sciences Jodhpur
Completed
Not Applicable
Evaluation of the safety and efficacy of continuous use of skincare formulationsHealthyJPRN-UMIN000039937Beauty & Health Research Inc.46
Recruiting
Phase 2
Assessment of efficacy and safety of continouation maintenance therapy with gemcitabine after cisplatin-gemcitabine induction chemotherapy in advanced squamous cell lung cancer (KTORG1302)squamous cell lung cancerJPRN-UMIN000010721Kyoto Thoracic Oncology Research Group (KTORG)60
Not yet recruiting
Phase 3
A clinical trial to study the effects of two drugs, sustained release and immediate release mucoregulator in patients with bronchial asthma.CTRI/2010/091/000571Sun Pharmaceutical Industries Ltd.200